Synthon Pharmaceuticals

Synthon Pharmaceuticals – Product Catalog (A–Z)

Azacitidine (generic) → Indication: Myelodysplastic syndromes (MDS), AML → Dose: Injection vials 100 mg

Bortezomib (generic) → Indication: Multiple myeloma, mantle cell lymphoma → Dose: Injection vials 3.5 mg

Docetaxel (generic) → Indication: Breast, lung, prostate, gastric cancers → Dose: Injection vials 20–160 mg

Doxorubicin (generic) → Indication: Breast cancer, hematologic malignancies, sarcomas → Dose: IV infusion vials 10–50 mg

Gemcitabine (generic) → Indication: Pancreatic, lung, breast, bladder cancers → Dose: IV infusion vials 200–1000 mg

Leuprorelin acetate (generic) → Indication: Prostate cancer, endometriosis, uterine fibroids → Dose: Depot injection 3.75 mg, 11.25 mg

Letrozole (generic) → Indication: Hormone receptor-positive breast cancer → Dose: Tablets 2.5 mg

Methotrexate (generic, oncology + autoimmune use) → Indication: Leukemia, RA, psoriasis → Dose: Tablets 2.5–10 mg; injection vials/pens

Paclitaxel (generic) → Indication: Ovarian, breast, lung cancers, Kaposi’s sarcoma → Dose: IV infusion vials 30–300 mg

Rituximab (biosimilar candidate) → Indication: NHL, CLL, RA, autoimmune diseases → Dose: IV infusion vials 100–500 mg

Teriflunomide (generic development) → Indication: Multiple sclerosis (relapsing forms) → Dose: Tablets 7 mg, 14 mg

Topotecan (generic) → Indication: Ovarian, small-cell lung cancers → Dose: IV infusion vials 1 mg, 4 mg

Trastuzumab (biosimilar candidate) → Indication: HER2+ breast & gastric cancer → Dose: IV infusion vials 150 mg, 420 mg

Valproic Acid / Sodium Valproate (generics) → Indication: Epilepsy, bipolar disorder, migraine prophylaxis → Dose: Tablets 200–500 mg; oral solution; IV